Manufacturer profile
Bestmade Natural Products
Pharmaceutical company5 products tracked
5
products tracked
396,976
total reports
47
recalls on record
53.3%
serious overall
Products
Recall history · 34 on record
| Date | Class | Reason | Firm |
|---|---|---|---|
| May 17, 2024 | III | Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR. | GlaxoSmithKline LLC |
| Feb 2, 2024 | II | Subpotent Drug: Out of specification for assay | Bausch Health Companies, Inc. |
| Sep 30, 2022 | II | cGMP Deviations: Out of specification for assay of one of the preservative ingredients. | VistaPharm, Inc. |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | I | Microbial Contamination of Non-Sterile Products. | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | I | Microbial Contamination of Non-Sterile Products. | Plastikon Healthcare LLC |
| Jun 7, 2022 | I | Microbial Contamination of Non-Sterile Products | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Jun 7, 2022 | I | Microbial Contamination of Non-Sterile Products. | Plastikon Healthcare LLC |
| Jun 7, 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| Mar 24, 2022 | I | Microbial Contamination of Non-Sterile Products | Plastikon Healthcare LLC |
| Mar 24, 2022 | I | Microbial Contamination of Non-Sterile Products | Plastikon Healthcare LLC |
| Mar 24, 2022 | II | CGMP Deviations: Failure to properly investigate failed microbial testing. | Plastikon Healthcare LLC |
| Mar 24, 2022 | II | CGMP Deviations: Failure to properly investigate failed microbial testing. | Plastikon Healthcare LLC |
| Feb 22, 2022 | II | Impurity failure at 0-time of the repackaged lot. | American Health Packaging |
| Nov 1, 2021 | II | cGMP Deviations: Product manufactured with contaminated raw ingredient. | Precision Dose Inc. |
| Nov 1, 2021 | II | cGMP Deviations: Product manufactured with contaminated raw ingredient. | Precision Dose Inc. |
| Mar 8, 2021 | II | Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing | Akorn, Inc. |
| Jun 23, 2020 | III | Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification. | VistaPharm, Inc. |
| Nov 13, 2019 | II | CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API. | Precision Dose Inc. |
| Nov 1, 2019 | II | CGMP Deviations: Presence of NDMA impurity detected in product. | American Health Packaging |
| Mar 25, 2019 | II | Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date. | Lohxa LLC |
| Sep 21, 2017 | II | Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%. | Medline Industries Inc |
| May 17, 2017 | III | Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification. | VistaPharm, Inc. |
| Jan 8, 2016 | II | Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups. | Perrigo Company PLC |
| Mar 17, 2015 | II | Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. | Akorn, Inc. |
| Nov 14, 2014 | II | Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin. | Attix Pharmaceuticals |
| Mar 21, 2013 | II | Labeling: Not Elsewhere Classified: This unit dose product is being recalled because the product's name includes the word "Children's" which is misleading since the 650 mg dose of acetaminophen contained within it, is an adult dose. | Precision Dose Inc. |
| Jan 19, 2011 | III | Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed "5 mL x 50," instead of "10 mL x 50," | VistaPharm, Inc. |
Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm.
Registration status
Some products from Bestmade Natural Products are not FDA-registered for human use. For unregistered substances (peptides, SARMs without human registration), no legitimate human-use supplier exists. The absence of a sourcing route is the safety information.